Glipizide Xl (glipizide recalls
The FDA has published 2 recalls involving Glipizide Xl (glipizide since 2014. The latest was reported on 17 Oct 2018. Most were for potency & assay. Pfizer has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 Oct 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why glipizide xl (glipizide is recalled
Companies
By year
All glipizide xl (glipizide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Glipizide XL (glipizide) extended-release tablets 5 mg recalled | Pfizer | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Glipizide XL (glipizide) extended release tablets, 5 mg recalled | Greenstone | Potency & Assay | Nationwide |
Should you stop taking Glipizide Xl (glipizide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.